Low-risk gestational trophoblastic neoplasia (FIGO score 0 to 6)

What changed: Low-risk gestational trophoblastic neoplasia (FIGO score 0 to 6)

Cancer page →

Every dated change on the records linked to Low-risk gestational trophoblastic neoplasia (FIGO score 0 to 6), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Milestone6This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-18This recordLow-risk gestational trophoblastic neoplasia (FIGO score 0 to 6)
Facts on this page last checked
When this page itself was last checked or edited.

2020 · 1

2020MilestoneAvelumab
TROPHIMMUN: avelumab cures most women with single-agent-resistant low-risk disease
A milestone in how this cancer is treated.

2011 · 1

2011MilestoneDactinomycin (actinomycin D)
GOG 174: pulsed actinomycin D beats weekly methotrexate on complete response
A milestone in how this cancer is treated.

2000 · 1

2000MilestoneDisease-specific staging and risk systems (FIGO, Ann Arbor, IPI, R-ISS, ELN, IMDC)
FIGO adopts the combined anatomical stage and prognostic score
A milestone in how this cancer is treated.

1973 · 1

1973MilestoneTumour markers (CEA, LDH, chromogranin, thyroglobulin)
Charing Cross Hospital centralises registration and treatment in the United Kingdom
A milestone in how this cancer is treated.

1964 · 1

1964MilestoneDactinomycin (actinomycin D)
Actinomycin D established as a second single agent
A milestone in how this cancer is treated.

1956 · 1

1956MilestoneMethotrexate
Min Chiu Li cures metastatic choriocarcinoma with methotrexate, the first chemotherapy cure of a solid tumour
A milestone in how this cancer is treated.